Mieke Van Hemelrijck: The importance of Core Outcome Sets in clinical research
Mieke Van Hemelrijck, Professor of Cancer Epidemiology at King’s College London, shared a post on LinkedIn:
“Whilst some of TOUR: Transforming cancer Outcomes through Research are in Brussels for European Cancer Organisation Cancer Summit, Ailbhe Lawlor was representing us in Barcelona at ISPOR—The Professional Society for Health Economics and Outcomes Research.
The importance of Core Outcome Sets in clinical research – PIONEER – Big Data in Prostate Cancer EORTC – European Organisation for Research and Treatment of Cancer
And Io Wens presented work of on patient preferences – another collaboration with the EORTC – European Organisation for Research and Treatment of Cancer.
Well done!”
Mieke Van Hemelrijck is a Professor of Cancer Epidemiology at King’s College London. She serves as a Board Member of the European Organisation for Research and Treatment of Cancer (EORTC) and holds the position of Honorary Associate Professor at University College London (UCL). Additionally, she is a Visiting Scientist at Karolinska Institute.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023